Cyclophosphamide in the management of Ewing's sarcoma
Open Access
- 1 June 1967
- Vol. 20 (6), 961-966
- https://doi.org/10.1002/1097-0142(196706)20:6<961::aid-cncr2820200605>3.0.co;2-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Studies on the Hydrolysis of Cyclophosphamide. I. Identification of N-(2-Hydroxyethyl)-N'-(3-hydroxypropyl)ethylenediamine as the Main Product1Journal of the American Chemical Society, 1965
- Cyclophosphamide in the management of advanced bronchial carcinoma.Thorax, 1965
- Clinical and biochemical effects of cyclophosphamide in patients with malignant carcinoidAmerican Journal Of Medicine, 1965
- Cyclophosphamide Therapy in Childhood NeuroblastomaNew England Journal of Medicine, 1964
- Comparison of cyclophosphamide (cytoxan) and uracil mustard (U-8344) in chronic granulocytic leukemiaCancer, 1964
- CyclophosphamideJAMA, 1963
- Cyclophosphamide in the treatment of common neoplastic diseases of childhoodThe Journal of Pediatrics, 1962
- Cyclophosphamide in Treatment of Disseminated Malignant DiseaseBMJ, 1961
- Synthese und Abbau cytostatisch wirksamer cyclischer N‐Phosphamidester des Bis‐(β‐chloräthyl)‐aminsAngewandte Chemie, 1958
- Histochemical Demonstration of Sites of Phosphamidase Activity.Experimental Biology and Medicine, 1948